GM - CSF Human |
|||
PR27068 | Neuromics | 2 ug | EUR 229.2 |
G - CSF Human |
|||
PR27066-B | Neuromics | each | EUR 315 |
GM - CSF Human |
|||
PR27068-B | Neuromics | each | EUR 184.5 |
Human M-CSF / CSF-1 Protein, His Tag |
|||
MCF-H5247 | ACROBIOSYSTEMS | 50ug | EUR 5253.7 |
Description: Human M-CSF, His Tag (MCF-H5247) is expressed from human 293 cells (HEK293). It contains AA Glu 33 - Arg 255 (Accession # P09603-1). |
Active Recombinant Human CSF-1/M-CSF Protein |
|||
RP01221 | Abclonal | 10 μg | EUR 113.75 |
Active Recombinant Human CSF-2/GM-CSF Protein |
|||
RP00094 | Abclonal | 5 μg | EUR 39 |
Human M-CSF / CSF-1 Protein, premium grade |
|||
MCF-H5218 | ACROBIOSYSTEMS | 1mg | EUR 171.2 |
Description: Human M-CSF Protein, premium grade (MCF-H5218) is expressed from human 293 cells (HEK293). It contains AA Glu 33 - Arg 255 (Accession # P09603-1). |
Recombinant human M-CSF/CSF-1 Protein, His Tag |
|||
E40KMP1005 | EnoGene | 20ug | EUR 495 |
Human CSF-1 ELISA Kit |
|||
EHC0117 | Abclonal | 96Tests | EUR 625.2 |
GM - CSF Human Pichia |
|||
PR27070 | Neuromics | 2 ug | EUR 177.6 |
GM - CSF Human Pichia |
|||
PR27070-B | Neuromics | each | EUR 184.5 |
Biotinylated Human M-CSF / CSF-1 Protein, His,Avitag™ |
|||
MCF-H82E6 | ACROBIOSYSTEMS | 25ug | EUR 1647.8 |
Description: Biotinylated Human M-CSF, His,Avitag (MCF-H82E6) is expressed from human 293 cells (HEK293). It contains AA Glu 33 - Arg 255 (Accession # P09603-1). |
Recombinant Human G-CSF (CSF3) |
|||
Z100245 | ABM | 10 µg | EUR 50 |
Description: G-CSF is secreted by monocytes, macrophages, and neutrophils after cell activation. It is also produced by stromal cells, fibroblasts, endothelial cells, epithelial carcinomas, acute myeloid leukemia cells, and various tumor cell lines. The synthesis of G-CSF can be induced by bacterial endotoxins, TNF, IL1 and GM-CSF. Comparison of the primary sequence of G-CSF with those of GM-CSF and M-CSF, shows that the three factors are not related to each other. Murine and human G-CSF share a sequence homology (protein) of approximately 70% and exhibit cross reactivity. G-CSF stimulates the proliferation and differentiation of hematopoietic progenitor cells committed to the neutrophils and granulocytes lineage in a dose-dependent manner. |
Recombinant Human G-CSF (CSF3) |
|||
Z100247 | ABM | 50 µg | EUR 150 |
Description: G-CSF is secreted by monocytes, macrophages, and neutrophils after cell activation. It is also produced by stromal cells, fibroblasts, endothelial cells, epithelial carcinomas, acute myeloid leukemia cells, and various tumor cell lines. The synthesis of G-CSF can be induced by bacterial endotoxins, TNF, IL1 and GM-CSF. Comparison of the primary sequence of G-CSF with those of GM-CSF and M-CSF, shows that the three factors are not related to each other. Murine and human G-CSF share a sequence homology (protein) of approximately 70% and exhibit cross reactivity. G-CSF stimulates the proliferation and differentiation of hematopoietic progenitor cells committed to the neutrophils and granulocytes lineage in a dose-dependent manner. |
Recombinant Human G-CSF (CSF3) |
|||
Z100249 | ABM | 1.0 mg | EUR 2640 |
Description: G-CSF is secreted by monocytes, macrophages, and neutrophils after cell activation. It is produced also by stromal cells, fibroblasts, endothelial cells, epithelial carcinomas, acute myeloid leukemia cells, and various tumor cell lines. The synthesis of G-CSF can be induced by bacterial endotoxins, TNF, IL-1 and GM-CSF. Comparison of the primary sequence of G-CSF with those of the two other colony stimulating factors, GM-CSF and M-CSF, shows that the three factors are not related to each other. Murine and human G-CSF show a sequence homology of approximately 70% at the DNA level and 72% at the protein level. The G-CSF receptor, CD114, is expressed on all cells of the neutrophils and granulocytes lineage. It is expressed also in placenta cells, endothelial cells and various carcinoma cell lines. Human G-CSF is active in murine cells and vice versa. G-CSF stimulates the proliferation and differentiation of hematopoietic progenitor cells committed to the neutrophils and granulocytes lineage in a dose-dependent manner. G-CSF synergises with some other cytokines, including GM-CSF and IL-4. GM-CSF and G-CSF are required, for example, to develop neutrophilic colonies in vitro. The concerted action of G-CSF and Epo is required to support the growth of mixed colonies of the early erythroid progenitors. A combination of IL-4 with G-CSF has been shown to lead to synergistic suppression of the growth of some human leukemic cell lines. |
Recombinant Human M-CSF (CSF1) |
|||
Z100655 | ABM | 10 µg | EUR 235 |
Description: M-CSF is produced by monocytes, granulocytes, endothelial cells, and fibroblasts. After cell activation, B cells and T cells and also a number of tumor cell lines are capable also of synthesizing this factor. M-CSF has been found to be synthesized by uterine epithelial cells in vivo. The M-CSF receptor is identical with the proto-oncogene fms. It has been renamed CD115. The receptor is a transmembrane protein with an extracellular ligand-binding domain of 512 amino acids, an intramembrane domain of 25 amino acids, and a cytoplasmic domain of 435 amino acids encoding a tyrosine kinase. Human M-CSF is active in mouse and rat cells. The murine factor is active in rat cells but inactive in human cells. M-CSF is a specific factor in that the proliferation inducing activity is more or less restricted to the macrophage lineage. M-CSF is a potent stimulator of functional activities of monocytes. |
Recombinant Human M-CSF (CSF1) |
|||
Z100659 | ABM | 1.0 mg | EUR 6900 |
Description: M-CSF is produced by monocytes, granulocytes, endothelial cells, and fibroblasts. After cell activation, B cells and T cells and also a number of tumor cell lines are capable also of synthesizing this factor. M-CSF has been found to be synthesized by uterine epithelial cells in vivo. The M-CSF receptor is identical with the proto-oncogene fms. It has been renamed CD115. The receptor is a transmembrane protein with an extracellular ligand-binding domain of 512 amino acids, an intramembrane domain of 25 amino acids, and a cytoplasmic domain of 435 amino acids encoding a tyrosine kinase. Human M-CSF is active in mouse and rat cells. The murine factor is active in rat cells but inactive in human cells. M-CSF is a specific factor in that the proliferation inducing activity is more or less restricted to the macrophage lineage. M-CSF is a potent stimulator of functional activities of monocytes. |
Recombinant Human M-CSF/ CSF-1 Protein, His, Yeast-1mg |
|||
QP9081-ye-1mg | EnQuireBio | 1mg | EUR 2262 |
Recombinant Human GM-CSF (CSF2) |
|||
Z100275 | ABM | 20 µg | EUR 85 |
Description: GM-CSF is a hematopoietic growth factor that is produced by endothelial cells, monocytes, fibroblasts and T-lymphocytes following their activation by antigens or mitogens. GM-CSF stimulates the development of macrophages and neutrophils and plays a role in the proliferation and development of early erythroid megakaryocytic and eosinophilic progenitor cells. Approximately 90% of the secreted colony stimulating activities are due to GM-CSF. While non-glycosylated and glycosylated GM-CSF show similar activities in vitro, fully glycosylated GM-CSF is biologically more active in vivo compared to its non-glycosylated counterpart. Human and murine GM-CSF are species-specific and therefore, exhibit no cross-reactivity. Recombinant Human GM-CSF is a non-glycosylated, monomeric protein that contains intra-chain disulfide bonds. |
Recombinant Human GM-CSF (CSF2) |
|||
Z100277 | ABM | 100 µg | EUR 210 |
Description: GM-CSF is a hematopoietic growth factor that is produced by endothelial cells, monocytes, fibroblasts and T-lymphocytes following their activation by antigens or mitogens. GM-CSF stimulates the development of macrophages and neutrophils and plays a role in the proliferation and development of early erythroid megakaryocytic and eosinophilic progenitor cells. Approximately 90% of the secreted colony stimulating activities are due to GM-CSF. While non-glycosylated and glycosylated GM-CSF show similar activities in vitro, fully glycosylated GM-CSF is biologically more active in vivo compared to its non-glycosylated counterpart. Human and murine GM-CSF are species-specific and therefore, exhibit no cross-reactivity. Recombinant Human GM-CSF is a non-glycosylated, monomeric protein that contains intra-chain disulfide bonds. |
Recombinant Human GM-CSF (CSF2) |
|||
Z100279 | ABM | 10 x 100 µg (Z100277 x 10) | EUR 1980 |
Description: GM-CSF is a monomeric protein of 127 amino acids with two glycosylation sites. The protein is synthesized as a precursor of 144 amino acids, which included a hydrophobic secretory signal sequence at the amino terminal end. The sugar moiety is not required for the full spectrum of biological activities. Non-glycosylated and glycosylated GM-CSF show the same activities in vitro. Fully glycosylated GM-CSF is biologically more active in vivo than the non-glycosylated protein. This protein is secreted together with other factors by T cells and macrophages following cell activation by antigens or mitogens. Approximately 90% of the secreted colony stimulating activities are due to GM-CSF. |
Recombinant Human M-CSF/ CSF-1 Protein, His, Yeast-10ug |
|||
QP9081-ye-10ug | EnQuireBio | 10ug | EUR 283.2 |
Recombinant Human M-CSF/ CSF-1 Protein, His, Yeast-50ug |
|||
QP9081-ye-50ug | EnQuireBio | 50ug | EUR 358.8 |
Recombinant Human M-CSF/ CSF-1 Protein, His, Yeast-100ug |
|||
QP9081-ye-100ug | EnQuireBio | 100ug | EUR 576 |
Recombinant Human M-CSF/ CSF-1 Protein, His, Yeast-200ug |
|||
QP9081-ye-200ug | EnQuireBio | 200ug | EUR 892.8 |
Recombinant Human M-CSF/ CSF-1 Protein, His, Yeast-500ug |
|||
QP9081-ye-500ug | EnQuireBio | 500ug | EUR 1447.2 |
Recombinant Human M-CSF/ CSF-1 Protein, Untagged, E.coli-1mg |
|||
QP5223-1mg | EnQuireBio | 1mg | EUR 4864.8 |
Recombinant Human M-CSF/ CSF-1 Protein, Untagged, E.coli-2ug |
|||
QP10351-ec-2ug | EnQuireBio | 2ug | EUR 184.8 |
Recombinant Human M-CSF/ CSF-1 Protein, Untagged, E.coli-10ug |
|||
QP10351-ec-10ug | EnQuireBio | 10ug | EUR 348 |
Human CSF1 / M-CSF, Fc Tag |
|||
E24PHA183 | EnoGene | 50 μg | EUR 200 |
Recombinant Human M-CSF/ CSF-1 Protein, Untagged, E.coli-500ug |
|||
QP5223-500ug | EnQuireBio | 500ug | EUR 3003.6 |
Recombinant Human M-CSF/ CSF-1 Protein, Untagged, E.coli-100ug |
|||
QP10351-ec-100ug | EnQuireBio | 100ug | EUR 1675.2 |
Recombinant Human M-CSF/ CSF-1 Protein, Untagged, E.coli-250ug |
|||
QP10351-ec-250ug | EnQuireBio | 250ug | EUR 2948.4 |
Human CSF1 / M-CSF, His Tag |
|||
E24PHA184 | EnoGene | 50 μg | EUR 262 |
Human CSF2 / GM-CSF, Fc Tag |
|||
E24PHA637 | EnoGene | 50 μg | EUR 200 |
Human CSF2 / GM-CSF, His Tag |
|||
E24PHA638 | EnoGene | 50 μg | EUR 200 |
Recombinant Human G-CSF/CSF3 Protein |
|||
E40KMP1619 | EnoGene | 20ug | EUR 495 |
Recombinant Human G-CSF/CSF1 Protein |
|||
RP00472 | Abclonal | 10 μg | EUR 265.2 |
Recombinant Human G-CSF/CSF3 Protein |
|||
RP01722 | Abclonal | 50μg | EUR 81.25 |
Recombinant Human G-CSF/CSF3 Protein |
|||
PDEH100077-100ug | Elabscience Biotech | 100ug | EUR 118 |
Description: Human |
Recombinant Human G-CSF/CSF3 Protein |
|||
PDEH100077-20ug | Elabscience Biotech | 20ug | EUR 68 |
Description: Human |
Recombinant Human G-CSF/CSF3 Protein |
|||
PKSH033663-10ug | Elabscience Biotech | 10ug | EUR 178 |
Description: Human |
Recombinant Human G-CSF/CSF3 Protein |
|||
PKSH033663-50ug | Elabscience Biotech | 50ug | EUR 523 |
Description: Human |
Human CSF3R/G-CSF R ELISA Kit |
|||
EK5326 | SAB | 96 tests | EUR 599 |
Human CSF2/GM-CSF Protein, Fc Tag |
|||
E40KMPH1138 | EnoGene | 20ug | EUR 495 |
Description: Antigen Grade |
Human CSF2/GM-CSF Protein, Fc Tag |
|||
E40KMPH1140 | EnoGene | 20ug | EUR 495 |
Description: Recombinant Human Cytotoxic T-lymphocyte Protein 4 is produced by our Mammalian expression system and the target gene encoding Lys36-Asp161 is expressed with a Flag tag at the C-terminus. |
Human CSF2/GM-CSF Protein, Fc Tag |
|||
E40KMPH1141 | EnoGene | 20ug | EUR 495 |
Pooled Human Cerebrospinal Fluid (CSF) |
|||
IRHUCSF1ML | Innovative research | each | EUR 322 |
Description: Pooled Human Cerebrospinal Fluid (CSF) |
Pooled Human Cerebrospinal Fluid (CSF) |
|||
IRHUCSF5ML | Innovative research | each | EUR 1045 |
Description: Pooled Human Cerebrospinal Fluid (CSF) |
Human CSF2/GM-CSF Protein, His Tag |
|||
E40KMPH1139 | EnoGene | 20ug | EUR 495 |
Description: LFA, EIA,CLIA,WB |
Synthetic Human Cerebrospinal Fluid (CSF) |
|||
IRHUCSFSYT25ML | Innovative research | each | EUR 1315 |
Description: Synthetic Human Cerebrospinal Fluid (CSF) |
Human CMV IgG(CSF) ELISA Kit |
|||
DEIA464 | Creative Diagnostics | 96T | EUR 780 |
Description: Human CMV IgG (CSF) ELISA kit is intended for in vitro diagnosis of CMV- associated diseases, i.e. infectious mononucleosis, CMV syndrome, hepatitis in infants, intersticial pneumonitis or other forms of active CMV infection in immunocompromised patients, |
CSF/ Rat CSF ELISA Kit |
|||
ELA-E1111r | Lifescience Market | 96 Tests | EUR 1063.2 |
Human M-CSF/CSF1 Antibody Pair Set |
|||
ABPR-ZB243 | Creative Diagnostics | 5 plates, 15 plates | Ask for price |
Description: Quantitative determination of Human M-CSF/CSF1 |
Human GM-CSF/CSF2 Antibody Pair Set |
|||
ABPR-ZB407 | Creative Diagnostics | 5 plates, 15 plates | Ask for price |
Description: Quantitative determination of Human GM-CSF/CSF2 |
Recombinant Human GM-CSF/CSF2 (E. coli) |
|||
AP74770 | SAB | 1mg | EUR 2599 |
Recombinant Human M-CSF/CSF1 (C-6His) |
|||
AP75122 | SAB | 1mg | EUR 3829 |
Recombinant Human M-CSF/CSF1 (C-6His) |
|||
C417-10ug | Novoprotein | 10ug | EUR 242.4 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.2. |
Recombinant Human M-CSF/CSF1 (C-6His) |
|||
C417-1mg | Novoprotein | 1mg | EUR 3274.8 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.2. |
Recombinant Human M-CSF/CSF1 (C-6His) |
|||
C417-500ug | Novoprotein | 500ug | EUR 2312.4 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.2. |